P-405 EXCALIBER-RRMM: A Phase 3, Two-Stage Trial of Iberdomide, Daratumumab, Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, Dexamethasone (DVd) in Patients With Relapsed/Refractory Multiple Myeloma
作者
Sagar Lonial,Hang Quach,Meletios Athanasios Dimopoulos,Paula Rodríguez‐Otero,Jesús G. Berdeja,Paul Gerard Guy Richardson,Margee J. Kyada,Sakiko Kuroda,Shuyu Chu,Paulo Maciag,Patricia C. Abad,Juliane Morando,Niels W.C.J. van de Donk